Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

MANDATE: NBK FI Inv Calls 6/30-7/1 for US$ PerpNC6 AT1 Bond Offering

IGC US Market: Deal Flow - GeneralIGC European Market: Deal Flow - General

The National Bank of Kuwait S.A.K.P. (“NBK” or the “Bank”), the leading bank in Kuwait and the largest by total assets, customer deposits and customer loans and advances, rated A1 / A / A+ (all stable, by Moody's / S&P / Fitch), has mandated Citi, HSBC, J.P. Morgan, and Standard Chartered Bank as Joint Global Coordinators, along with Abu Dhabi Commercial Bank, Emirates NBD Capital, First Abu Dhabi Bank, Kamco Invest and National Bank of Kuwait as Joint Lead Managers and Joint Bookrunners to arrange two Global Investor Calls and a series of fixed income investor calls on Monday 30th June and Tuesday 1st July, 2025. A fixed rate resettable non-call 6-year USD benchmark Rule 144A/Reg S Perpetual Tier 1 Capital offering (the “New Capital Securities”), expected to be rated Baa3 by Moody's, issued by NBK Tier 1 Limited will follow, subject to market conditions.

FCA/ICMA stabilization applies

In addition, NBK has separately announced an invitation to the holders of its outstanding U.S.$ 750,000,000 Perpetual Tier 1 Capital Securities issued by NBK Tier 1 Financing (2) Limited (the “Existing Capital Securities”) to tender for cash purchase any and all such Existing Capital Securities, subject to the satisfaction or waiver of the conditions described in the Tender Offer Memorandum dated Monday 30th June, 2025. Citi, HSBC, J.P. Morgan, and Standard Chartered Bank are appointed as The Dealer Managers. The Expiration Deadline for the tender is 17:00 NYT on Tuesday 8th July, 2025. For further information on the offer, holders should (subject to offer and distribution restrictions) refer to the Tender Offer Memorandum

We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.